The 2015 portfolio emphasizes translational and clinical research to advance 2020 goal. View in a web browser.

leadership
Message
Our guest columnist this month is Steven Leach, MD. Dr. Leach is chair-elect of the Pancreatic Cancer Action Network’s Scientific and Medical Advisory Board (SMAB) and is currently serving as chair of the newly formed SMAB Research Committee. Read his perspective on the 2015 Research Grants Program.




Learn more about pancreatic cancer and its treatment — and gain hope — by attending a local educational event in person or watching a webinar online anytime. Explore your options.




shop
purple
Clearance sale on unisex polo shirts — buy yours now!




learn about
planned giving
Create your legacy with a planned gift.




make a
monthly donation
Join our Circle of Hope.

 

2015 Research Grants Program Launches
The Pancreatic Cancer Action Network will award $4.1 million in grants to researchers at all career levels in 2015, focusing on translational and clinical research. Scientists and clinicians are applying now. Read more.


PurpleLight:
Honor. Inspire. Remember.
Registration is now in progress for many fall PurpleLight events. Check the event listing now to see if registration is open for an event near you, and check back often for updates!
Lessons in Adventure and Bravery: Remembering Michael Landon
Michael Landon’s children Jennifer and Sean share treasured memories of a dad taken too soon by pancreatic cancer. Remember with them.
Instead of a Gown or a Tux ...
Our traditional An Evening With the Stars gala is on hiatus this year. Stay tuned for more information, coming soon, about our "non-event" fundraiser ... An Evening at Home gala!
Steven Leach, MD, Named Chair-Elect of Scientific and Medical Advisory Board
Dr. Steven Leach, Director of the David M. Rubenstein Center for Pancreatic Cancer Research and an attending physician at Memorial Sloan-Kettering Cancer Center, will chair the Pancreatic Cancer Action Network’s Scientific and Medical Advisory Board starting in July 2015. Read more.
Pancreatic Cancer Action Network Speaks Out About Clinical Trial Enrollment
Following an interview with Julie Fleshman and Lynn Matrisian, an August 15 article in the San Francisco Business Times (circulation of 18,000) featured the organization’s viewpoint on the importance of educating patients about clinical trials. Read the article.
dear
friend:

Thank you for supporting one of the Pancreatic Cancer Action Network's signature events. We have included you on the distribution list for our monthly e-newsletter, Pancreas Matters, so you can learn more about our mission and the impact of your support.

To edit your email preferences with us, click here.

We also invite you to learn more about upcoming events in your area.


Help us continue to make progress toward our goal of doubling pancreatic cancer survival by 2020.


 
Share this email
Facebook  Twitter  Addthis

 

Join the conversation!
Privacy Policy
Manage your subscriptions
Unsubscribe

The Pancreatic Cancer Action Network is a nationwide network of people dedicated to working together to advance research, support patients and create hope for those affected by pancreatic cancer.

National Office | 1500 Rosecrans Avenue, Suite 200, Manhattan Beach, CA 90266 | 310-725-0025
Government Affairs & Advocacy | 1050 Connecticut Ave. NW, 10th Floor, Washington, DC 20036 | 202-742-6699

© 2014 Pancreatic Cancer Action Network. All rights reserved. Pancreatic Cancer Action Network is a qualified 501(c)(3) tax-exempt organization.
PANCREATIC CANCER ACTION NETWORK®, PANCAN®, PURPLESTRIDE® and TEAMHOPE® are registered trademarks of Pancreatic Cancer Action Network, Inc.